SecBot SecBot
SECBOTREPLAY Home › Report › RVMDW

RVMDW · Mark A

Revolution Medicines, Inc. · 144 filed Apr 15, 2026 at 16:53 ET

At the news

BEARISHIMPACT 6/10

144 filed Apr 15, 2026 at 16:53 ET

Mark A. Goldsmith, a director and officer of Revolution Medicines, intends to sell up to 120,000 shares of common stock, valued at approximately $17.6 million, under a 10b5-1 plan. The sale is scheduled for April 15, 2026, and follows prior 10b5-1 sales by Goldsmith and affiliated trusts totaling over $4.6 million in March 2026.

  • Mark A. Goldsmith is a director and officer of Revolution Medicines (RVMDW).
  • He filed a Form 144 to sell up to 120,000 shares of common stock, valued at $17,641,200.
  • The sale is scheduled for April 15, 2026, under a 10b5-1 plan.
  • Goldsmith and affiliated trusts executed over $4.6 million in 10b5-1 sales in early March 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access